SIR: Bariatric Artery Embolization May Be New Weight-Loss Tool

Share this content:
SIR: Bariatric Artery Embolization May Be New Weight-Loss Tool
SIR: Bariatric Artery Embolization May Be New Weight-Loss Tool

TUESDAY, April 5, 2016 (HealthDay News) -- Bariatric artery embolization may offer another way to treat severe obesity, a preliminary study suggests. The findings were presented at the annual meeting of the Society of Interventional Radiology, held from April 2 to 7 in Vancouver, Canada.

"Our hypothesis is that (embolization) causes weight loss by lowering ghrelin production," lead author Clifford Weiss, M.D., an associate professor of radiology at Johns Hopkins University in Baltimore, told HealthDay. However, he added, that's not proven.

The study, of seven severely obese adults, found that the minimally invasive procedure caused no serious complications. It also spurred some weight loss: Patients lost 13 percent of their excess weight, on average, over the next six months.

The short-term risks include bleeding and infections, and in the long run, people can develop nutritional deficiencies and potentially dangerous hernias, according to the U.S. National Institutes of Health.

Press Release
More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths